People who wear reusable contact lenses are nearly four times as likely as those wearing daily disposables to develop a rare sight-threatening eye infection, finds a study led by UCL and Moorfields researchers.
It’s a phenomenon that we have probably all experienced. You’re in a packed place surrounded by a swirling mass of people, and someone looks you in the eye.
Claes H. Dohlman, MD, Phd, considered a founder of modern cornea science, was awarded the 2022 António Champalimaud Vision Award for his vast contributions to vision research. The award comes with a €1,000,000 prize, one of the largest in scientific research.
The House voted overwhelmingly today to reform prior authorization under the Medicare Advantage program to help ensure America’s seniors get the care they need when they need it.
The latest research and expert commentary on pain management.
Researchers from the National Eye Institute (NEI) have developed a gene therapy that rescues cilia defects in retinal cells affected by a type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood.
“Super-recognizers,” who account for about 2% of the population, rely not on photographic memories but “their ability to pick up highly distinctive visual information and put all the pieces of a face together like a puzzle, quickly and accurately.”
Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss. The study, published recently in the Biophysical Journal, describes the flexible structure of a key blood protein involved in macular degeneration and other age-related diseases, such as Alzheimer’s and atherosclerosis.
During September’s Healthy Aging Month, the American Society of Retina Specialists (ASRS) and its members encourage older Americans, their friends and family to learn the facts about retinal conditions that can steal sight as people age. Knowing the signs and symptoms of retinal diseases, incorporating healthy retina habits, and confirming that expert retina specialist care and advanced treatments are available without delay through insurance plans can help protect and preserve vision.
David J. Calkins, PhD, has been selected as the 2023 RPB David F. Weeks Award for Outstanding Vision Research.
The earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, researchers from UT Southwestern reported in a recent study. The findings, published in Clinical Ophthalmology, could lead to better screening protocols for POAG, which accounts for up to 90% of all cases of glaucoma.
Ann E. Elsner has been named the 2022 Charles F. Prentice Medal Award recipient by the American Academy of Optometry. The award is considered the most prestigious of the academy's awards for achievement in research.
When is the best time to take your child to see the eye doctor? How can you protect their vision during their formative years? A Penn State Health ophthalmologist dots the Is for you.
A metabolite of caffeine, known as 7-MX, may slow the progression of short-sightedness, also known as myopia, in children, suggests observational research published online in the British Journal of Ophthalmology.
Measuring how the eyes’ pupils change in response to light—known as the pupillary light reflex—could potentially be used to screen for autism in young children, according to a study conducted at Washington State University.
Lithophane is an ancient artistic medium but never used to represent scientific data and imagery in a quantitative, controlled manner for tactile visualization and integration. Lithophane combined with 3D printing is turning scientific data into tactile graphics for all to see by eyesight or touch.
Scientists have demonstrated that the APOE4 gene variant, which increases risk for Alzheimer’s but decreases risk of glaucoma in humans, blocks a disease cascade that leads to the destruction of retinal ganglion cells in glaucoma. Additionally, they showed in mouse models that the death of retinal ganglion cells – the cause of vision loss in glaucoma – can be prevented by using medications to inhibit a molecule called Galectin-3, which is regulated by the APOE gene. These findings taken together emphasize the critical role of APOE in glaucoma and suggest that Galectin-3 inhibitors hold promise as a glaucoma treatment, according to the authors.
TGF's Art Challenge is about vision, for vision. Our goal is to end glaucoma - the silent thief of sight. We invite everyone who makes art and everyone who appreciates their vision to join us in raising funds for sight-saving research.
In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies’ brand name eyedrops for glaucoma instead of cheaper generic versions.
Researchers and entrepreneurs have developed an implant made of collagen protein from pig’s skin, which resembles the human cornea.
The findings from the meeting were recently published in Molecular Neurodegeneration and raise opportunities for new treatments and cures for neurodegenerative diseases like glaucoma and Alzheimer’s.
Below are some of the latest articles that have been added to the Food Science channel on Newswise, a free source for journalists.
A recent study highlights the range of uncomfortable situations people living with blindness or visual impairment encounter due to interpersonal communication challenges, and outlines strategies people with visual impairment use to navigate these situations.
Award recipients to use the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) clinical database to improve care for all patients
With the support of Harrington Discovery Institute at University Hospitals (UH), an ophthalmic therapeutic dubbed KIO-301, which was initially developed by Richard Kramer, PhD, at the University of California, Berkeley (UCB), has successfully been granted approval to start a Phase 1b, first-in-human clinical trial. Currently under the stewardship of Kiora Pharmaceuticals, Inc., (NASDAQ: KPRX) via a license with UCB, Inc., the drug is intended to restore lost vision in patients with Retinitis Pigmentosa (RP)--a rare, genetic eye disease that causes severe loss of functional vision and affects an estimated 100,000 people in the U.S.
As has been demonstrated by many studies, contoured prism has historically shown efficacy in relieving symptoms as a therapeutic offering.
A new study in mice has revealed never-before-seen details about how the complicated visual network forms in them. This research could inform future research into the treatment of congenital blindness.
Mount Sinai study shows flavoprotein fluorescence could serve as new biomarker
Henry Ford Health has received a $2 million gift from the A.A. Van Elslander Foundation to establish the Philip C. Hessburg, M.D. - Art Van Elslander Chair in Ophthalmic Research, which will constitute a permanent endowment fund to support the educational research initiatives at Henry Ford Health by the Detroit Institute of Ophthalmology (DIO).
Using a new imaging technique, researchers from the National Eye Institute have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing effective treatments for this and other rare diseases. NEI is part of the National Institutes of Health.
The House Ways and Means Committee today voted unanimously to advance the Improving Seniors’ Timely Access to Care Act of 2022 (H.R. 8487), positioning the bill for passage in Congress possibly this fall.
Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).
Stuart Therapeutics, Inc. (Stuart), a clinical stage company developing advanced ophthalmic therapeutics, announced today that the United States Patent and Trademark office has issued a Notice of Allowance in each of two patent applications associated with the company's clinical product candidates, including ST-100, Stuart's drug candidate for the treatment of dry eye disease (DED) which recently completed a successful Phase 2 trial.
20240326113011.png&width=400&height=400){kind=logo}
In ACS Nano, researchers report a nanomembrane system that harvests and purifies tiny blobs called exosomes from tears, allowing researchers to quickly analyze them for disease biomarkers. Dubbed iTEARS, the platform could enable more efficient and less invasive diagnoses for many diseases.
Concussion is a common injury in childhood, affecting about 1.4 million children and adolescents annually in the United States. The good news is that most of these visual symptoms resolve on their own by four weeks.
Loss of the protein pigment epithelium-derived factor (PEDF), which protects retinal support cells, may drive age-related changes in the retina, according to a new study in mice from the National Eye Institute (NEI).
Cornell University researchers have provided the first documentation that dogs’ sense of smell is integrated with their vision and other unique parts of the brain, shedding new light on how dogs experience and navigate the world.
Stuart Therapeutics, Inc. (Stuart), a clinical stage company headquartered in Stuart, Florida that is developing advanced ophthalmic therapeutics, announced today the results of its Type C Guidance meeting with the U.S. Food and Drug Administration (FDA) regarding the continued development plan for ST-100, Stuart's first drug candidate for the treatment of Dry Eye Disease (DED) in humans.
Some parents may overlook simple steps to minimize eye injuries.
The American Society of Retina Specialists (ASRS) has released its first-ever national television and radio public service announcements (PSAs) to educate the public about protecting their vision from preventable blindness and vision loss due to retinal disease and the importance of expert retina specialist care.
The Neurodegeneration Initiative was launched through a transformative $2.4 million gift to Glaucoma Research Foundation from the Melza M. and Frank Theodore Barr Foundation.
Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.
University of Chicago Medicine study is the first to focus on paintball guns used as assault weapons with the intent to cause harm.
Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.
Finding could open new front in fight against disinformation
Our visual perception of the world is often thought of as relatively stable. However, like all of our cognitive functions, visual processing is shaped by our experiences.
Prosopagnosia, an ailment that made headlines this week after actor Brad Pitt announced that he is suffering from the disorder, is an uncommon brain malady that causes the inability to recognize faces.
The eye’s light-sensing retina taps different circuits depending on whether it is generating image-forming vision or carrying out a non-vision function such as regulating pupil size or sleep/wake cycles, according to a new mouse study from the National Eye Institute (NEI) and the National Institute of Mental Health (NIMH).
After a year of sustained advocacy from the ophthalmology community, Aetna announced this week that it will no longer require pre-approval for cataract surgeries starting July 1, 2022.
In a study of eye fluid from 38 patients, Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong, frequent eye injections to preserve vision or if they can be safely weaned off the treatments.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
